Previously treated cases tested for RR-/MDR-TB in Hong Kong, China
Hong Kong, China: Previously treated cases tested for RR-/MDR-TB was 87.0% in 2024. ▲ Rising
Previously treated cases tested for RR-/MDR-TB in Hong Kong, China, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for previously treated cases tested for rr-/mdr-tb in Hong Kong, China is 87.0%, measured in 2024.
Compared with earlier readings it is up 50.0% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Hong Kong, China peaked at 92.0% in 2019 and was at its lowest, 23.0%, in 2005.
That places Hong Kong, China 92nd out of 180 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Previously treated cases tested for RR-/MDR-TB in Hong Kong, China, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 23.0% | — |
| 2007 | 59.0% | +156.5% |
| 2008 | 55.0% | -6.8% |
| 2009 | 46.0% | -16.4% |
| 2010 | 41.0% | -10.9% |
| 2011 | 43.0% | +4.9% |
| 2012 | 48.0% | +11.6% |
| 2013 | 56.0% | +16.7% |
| 2014 | 58.0% | +3.6% |
| 2016 | 61.0% | +5.2% |
| 2017 | 60.0% | -1.6% |
| 2018 | 77.0% | +28.3% |
| 2019 | 92.0% | +19.5% |
| 2020 | 87.0% | -5.4% |
| 2021 | 91.0% | +4.6% |
| 2022 | 87.0% | -4.4% |
| 2023 | 87.0% | +0.0% |
| 2024 | 87.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 45.8% | 23.0% | 59.0% | 4 |
| 2010s | 59.6% | 41.0% | 92.0% | 9 |
| 2020s | 87.8% | 87.0% | 91.0% | 5 |
Countries ranked near Hong Kong, China
More health data for Hong Kong, China
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.0171 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 2,924 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2 deaths (2100)
- Population ages 50-54, male, annual growth rate -0.7678 % change on previous year (2025)
- Population ages 50-54, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 50-54, male, per capita 0.0318 units per person (2025)
- Population ages 55-59, female, annual growth rate -0.1829 % change on previous year (2025)
- Population ages 55-59, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 55-59, female, per capita 0.0438 units per person (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Hong Kong, China?
- Previously treated cases tested for rr-/mdr-tb in Hong Kong, China was 87.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Hong Kong, China?
- The highest recorded value was 92.0% in 2019.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Hong Kong, China?
- The lowest recorded value was 23.0% in 2005.
- How does Hong Kong, China rank for previously treated cases tested for rr-/mdr-tb?
- Hong Kong, China ranks 92nd out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Hong Kong, China?
- Over the last ten years it is up 50.0%. The long-run trend across the full record is rising.
- Where does this Hong Kong, China data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).